February 2, 2023 1:12 pm
Published by Fluidda
Pulmonary Hypertension (PH) patients need more treatment options, and it seems the Merck’s MK5475 inhaled drug is quite promising! FLUIDDA’s FRI technology showed substantial and homogeneous vasodilation throughout the lung... View Article
March 21, 2022 4:02 pm
Published by Fluidda
Lung deposition measured by Functional Respiratory Imaging (FRI) of inhaled LAMA via standard jet nebulizer or DPI. In a recently published study, FRI respiratory imaging was used to determine deposition patterns for... View Article
February 3, 2022 3:39 pm
Published by Fluidda
Functional Respiratory Imaging (FRI): in the transition from research to clinical practice? “Quantitative imaging of the airways, for example with functional respiratory imaging (FRI), is evolving from a research tool towards clinical... View Article
February 1, 2022 12:45 pm
Published by Fluidda
FRI offers early and rapid detection of lung diseases “Lung diseases often lead to irreversible damage. Early detection and start of the right treatment are therefore crucial. Functional Respiratory Imaging (FRI) makes rapid diagnosis and treatment possible.... View Article
January 27, 2022 1:12 pm
Published by Fluidda
Imaging of the pulmonary vasculature is crucial for our understanding of the short- and long-term consequences of COVID-19 Prof. William Li, president and medical director of the Angiogenesis Foundation, explains during an interview in... View Article
January 18, 2022 2:51 pm
Published by Fluidda
Functional Respiratory Imaging (FRI) quantifies and visualizes the distribution of blood vessels in the lungs in great detail. This simple model, which combines the results of the imaging with the... View Article
January 12, 2022 9:49 am
Published by Fluidda
The second edition of the Fluidda Magazine on FRI was recently published, containing several articles about how FRI is being used in clinical practice by radiologists and pulmonologists, especially during... View Article
July 9, 2021 3:20 pm
Published by Fluidda
A well powered study with FRI as primary endpoint shows the potential of an inhaled P13K delta inhibitor in COPD-exacerbations. A recent paper, published in the Int. Journal of Chronic Obstructive... View Article
March 19, 2021 12:40 pm
Published by Fluidda
In a recent publication in the European Respiratory Journal (ERJ) by Morris et al. a retrospective analysis was performed of chest CT scans of 313 COVID-19 positive and 195 COVID-19 negative patients seeking acute medical care. From... View Article